Walleye Trading’s Syndax Pharmaceuticals SNDX Stock Holding History

Walleye Trading’s Portfolio SNDX Stock Details SNDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$58.4K	Sell	2,500 -4,900	-66%	-$106K	﹤0.01%	3644
2025 Q4	$155K	Sell	7,400 -4,300	-37%	-$75K	﹤0.01%	3518
2025 Q3	$180K	Sell	11,700 -3,200	-21%	-$41.9K	﹤0.01%	3415
2025 Q2	$140K	Buy	+14,900	New	+$164K	﹤0.01%	3439
2023 Q3	–	Sell	-800	Closed	-$16.7K	–	5332
2023 Q2	$16.7K	Buy	+800	New	+$16.7K	﹤0.01%	4162
2022 Q1	–	Sell	-100	Closed	-$2K	–	5878
2021 Q4	$2K	Sell	100 -1,300	-93%	-$24K	﹤0.01%	5252
2021 Q3	$27K	Buy	+1,400	New	+$23.3K	﹤0.01%	4797

Other funds holding SNDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Walleye Trading's SNDX Position: Q1 2026 in Review

Walleye Trading opened a new position in Syndax Pharmaceuticals (SNDX) in Q1 2026: 416 shares worth $9.72K. The stake represents ﹤0.01% of the portfolio and ranks #3941 among its holdings. This is a return to the name: Walleye Trading previously reported a position in SNDX as recently as Q2 2025.

Walleye Trading first reported a position in SNDX in Q1 2019 and has held it in 8 quarters since. The position peaked at $2.44M in Q4 2021. 246 funds tracked by Wall St. Rank hold SNDX as of Q1 2026.

Walleye Trading held 416 shares of Syndax Pharmaceuticals worth $9.72K as of Q1 2026.
Syndax Pharmaceuticals was a new Walleye Trading position in Q1 2026.
Syndax Pharmaceuticals made up ﹤0.01% of Walleye Trading's portfolio in Q1 2026, its #3941 holding.
Walleye Trading first reported a position in Syndax Pharmaceuticals in Q1 2019 and has held it in 8 quarters since.
Walleye Trading's Syndax Pharmaceuticals position peaked at $2.44M in Q4 2021.
246 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.